BrainFrame ApS
CVRCVR number40738215
Company financials
Key figures
Updated 15 Jul 2026
- Return on assets
- -0%
- Return on equity
- -14.7%
- Current ratio
- 6.2%
- Equity ratio
- 85%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | -1,213 |
Operating profit | -1,213 |
Finance income | 774,209 |
Finance expenses | 38,949 |
Tax expense | 140,624 |
Profit/loss for the year | -1,004,989 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 0 |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 75,034 |
Current assets | 75,034 |
Non-current assets | 7,965,061 |
Total assets | 8,040,095 |
Equity | 6,831,383 |
Liabilities | 1,208,712 |
Current liabilities | 1,208,712 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 40,000 |
Retained earnings | 6,780,696 |
Investments and assets
| Reporting period | |
|---|---|
Long-term investments and receivables | 7,965,061 |
Annual report highlights
Official annual report · 2025
Business and development
Primary activities
Selskabets primære aktivitet består i at besidde kapitalandele i Tetra Pharm Technologies ApS.
Primary activities
1.
Virksomhedens væsentligste aktiviteter
Selskabets primære aktivitet består i at besidde kapitalandele i Tetra Pharm Technologies ApS.
Create a free account to see up to 9 years of financial history
Create free account